Pharmaceutical firms fared worse in 1Q

Published: 2012-05-09 07:00:00

Updated: 2012-05-09 07:00:00

Korea’s major pharmaceutical firms saw their earnings decline 43 percent for the first quarter of this year due to hurried disposal of drug inventories ahead of government-mandated cuts in drug prices in April 1.

According to the data compiled by Yakup.com, a pharmaceutical information provide...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK